Design Therapeutics (DSGN) Return on Sales (2020 - 2021)
Design Therapeutics' Return on Sales history spans 2 years, with the latest figure at 865.61% for Q3 2021.
- For Q3 2021, Return on Sales fell 74646.0% year-over-year to 865.61%; the TTM value through Sep 2021 reached 865.61%, changed N/A, while the annual FY2025 figure was 7.21%, 334.0% down from the prior year.
- Return on Sales for Q3 2021 was 865.61% at Design Therapeutics, down from 370.02% in the prior quarter.
- Across five years, Return on Sales topped out at 4.39% in Q1 2020 and bottomed at 865.61% in Q3 2021.